Brief: Abbott Receives FDA Approval For New Cardiomems Hf System Capabilities That Help Patients Engage In The Care Of Their Heart Condition
05/10/2026 14:12
BRIEF-Abbott Receives FDA Approval For New Cardiomems Hf System Capabilities That Help Patients Engage In The Care Of Their Heart Condition Abbott Laboratories ABT.N:
ABBOTT RECEIVES FDA APPROVAL FOR NEW CARDIOMEMS HF SYSTEM CAPABILITIES THAT HELP PATIENTS ENGAGE IN THE CARE OF THEIR HEART CONDITION
ABBOTT RECEIVES FDA APPROVAL FOR NEW CARDIOMEMS HF SYSTEM CAPABILITIES THAT HELP PATIENTS ENGAGE IN THE CARE OF THEIR HEART CONDITION
ABBOTT - CARDIOGUIDE HF APP AND DYNAMIC TREATMENT PLAN TO BE AVAILABLE LATER THIS YEAR
Source text: ID:nPn32xVP2a
Further company coverage: ABT.N
Recent news on Abbott Laboratories
See all newsStreet View: Abbott's nutrition spinoff to boost growth
US RESEARCH ROUNDUP-3M Company, Constellation Energy, Metropolitan Bank Holding
US STOCKS-Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
US STOCKS-Nasdaq leads Wall Street to higher close as SpaceX, Super Micro boost AI sentiment
Nestle, Zydus, Abbott face India scrutiny over claims on children's products (updated)